Literature DB >> 4227337

Iragapyrin toxicity.

L Ramakumar, B G Goyal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4227337     DOI: 10.1007/bf02756453

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  18 in total

1.  ACUTE LEUKAEMIA ASSOCIATED WITH PHENYLBUTAZONE TREATMENT.

Authors:  H J WOODLIFF; L DOUGAN
Journal:  Br Med J       Date:  1964-03-21

2.  ROLE OF DRUGS IN PRODUCTION OF GASTRODUODENAL ULCER.

Authors:  J L ROTH
Journal:  JAMA       Date:  1964-02-08       Impact factor: 56.272

3.  Multiple toxic effects of phenylbutazone; report of a fatal case.

Authors:  T N FRASER
Journal:  Br Med J       Date:  1955-05-28

4.  Hepatic necrosis and other visceral lesions associated with phenylbutazone therapy.

Authors:  J M MACCARTHY; R T JACKSON
Journal:  Br Med J       Date:  1955-07-23

5.  Acute renal failure caused by phenylbutazone.

Authors:  J H RICHARDSON; H H ALDERFER
Journal:  N Engl J Med       Date:  1963-04-11       Impact factor: 91.245

6.  The anti-thyroid effect of phenylbutazone.

Authors:  M E MORGANS; W R TROTTER
Journal:  Lancet       Date:  1955-07-23       Impact factor: 79.321

7.  Deaths of two patients treated by phenylbutazone.

Authors:  J G BENSTEAD
Journal:  Br Med J       Date:  1953-03-28

8.  Gastric ulcer with massive hemorrhage following use of phenylbutazone; report of a case.

Authors:  P KRAININ
Journal:  J Am Med Assoc       Date:  1953-05-02

9.  Hepatitis following the ingestion of phenylbutazone.

Authors:  E P ENGLEMAN; M A KRUPP; J F RINEHART; R C JONES; J R GIBSON
Journal:  J Am Med Assoc       Date:  1954-09-11

10.  Phenylbutazone.

Authors: 
Journal:  Br Med J       Date:  1965-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.